Radiopharmaceutical Imaging And Dosimetry
Radiopharmaceutical Imaging And Dosimetry is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
A multicenter, open-label, non-randomized Phase 1/2 study to assess safety, tolerability, and imaging characteristics of [68Ga]Ga-DPI-4452 and to assess safety, tolerability, and efficacy of [177Lu]Lu-DPI-4452 in patients with unresectable locally advanced or metastatic solid tumors
Sponsor ITM Oncologics GmbH
- Start (EU)
- Latest update
- Estimated end
An open-label, multicentre, integrated Phase 1 & 2 study to evaluate the safety, tolerability, radiation dosimetry and anti-tumour activity of Lutetium (177Lu) rhPSMA-10.1 injection in men with metastatic castrate-resistant prostate cancer
Sponsor Blue Earth Therapeutics Limited
- Start (EU)
- Latest update
- Estimated end
A Phase I/IIa open-label, multi-center study to evaluate the safety, tolerability, whole-body distribution, radiation dosimetry and anti-tumor activity of [177Lu]-NeoB administered in patients with advanced solid tumors known to overexpress gastrin-releasing peptide receptor (GRPR).
Sponsor Advanced Accelerator Applications International S.A.
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Radiopharmaceutical Imaging And Dosimetry?
The 2026-10-09 snapshot links Radiopharmaceutical Imaging And Dosimetry to 3 distinct CTIS trials. Recorded services include Dosimetry, dosimetry services, Laboratory services, Medical expertise, among 5 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Radiopharmaceutical Imaging And Dosimetry?
The most frequently recorded therapeutic areas are Endocrinology, Gastroenterology, Musculoskeletal, Neurology. Recorded phases include Phase 1, Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Radiopharmaceutical Imaging And Dosimetry conducted?
The linked trials record locations in 6 countries, including Belgium, France, Netherlands, Austria, Germany. These are trial locations, not confirmed office locations or countries where Radiopharmaceutical Imaging And Dosimetry delivered services.
What can this page tell me about Radiopharmaceutical Imaging And Dosimetry's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Radiopharmaceutical Imaging And Dosimetry. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Radiopharmaceutical Imaging And Dosimetry LLC